Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00110552 · ClinicalTrials.gov registry record · Phase 1
Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients
A Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 1
- Development phase
- 111
- Enrollment target
NCT00110552 is a Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 111 participants.
The verdict
NCT00110552, a Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease. Study hypothesis: The administration of sage will improve cognitive function in patients with mild Alzheimer's disease.
Interventions
- DRUG Salvia officinalis (sage)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2005-07 |
| Est. Completion | 2014-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00110552
The ClinicalTrials.gov registry entry for NCT00110552 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Salvia officinalis (sage) is the first listed.
NCT00110552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00110552 about?
NCT00110552 is a clinical study titled "Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients". The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease. Study hypothesis: The administration of sage will improve cognitive function in patients with mild Alzheimer's disease.
What is the current status of trial NCT00110552?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 111 participants. The study started on 2005-07. Estimated completion is 2014-10.
What interventions are being tested in trial NCT00110552?
The interventions under investigation include: Salvia officinalis (sage) (DRUG).
Who is sponsoring clinical trial NCT00110552?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.